These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 28637728

  • 1. Efficacy of long-acting release octreotide for preventing chemotherapy-induced diarrhoea: protocol for a systematic review.
    Deng C, Deng B, Jia L, Tan H.
    BMJ Open; 2017 Jun 21; 7(6):e014916. PubMed ID: 28637728
    [Abstract] [Full Text] [Related]

  • 2. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
    Rosenoff S.
    Support Care Cancer; 2004 Aug 21; 12(8):561-70. PubMed ID: 15160318
    [Abstract] [Full Text] [Related]

  • 3. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH.
    Eur J Cancer Care (Engl); 2004 Sep 21; 13(4):380-3. PubMed ID: 15305907
    [Abstract] [Full Text] [Related]

  • 4. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
    Hoff PM, Saragiotto DF, Barrios CH, del Giglio A, Coutinho AK, Andrade AC, Dutra C, Forones NM, Correa M, Portella Mdo S, Passos VQ, Chinen RN, van Eyll B.
    J Clin Oncol; 2014 Apr 01; 32(10):1006-11. PubMed ID: 24516038
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH, Gabrail NY, Conklin R, Hohneker JA, Berg WJ, Warsi G, Maloney J, Benedetto JJ, Miles EA, Zhu W, Anthony L.
    J Support Oncol; 2006 Jun 01; 4(6):289-94. PubMed ID: 16805331
    [Abstract] [Full Text] [Related]

  • 6. Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article.
    Bhattacharya S, Vijayasekar C, Worlding J, Mathew G.
    Acta Gastroenterol Belg; 2009 Jun 01; 72(3):289-95. PubMed ID: 19902860
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of acupuncture for chemotherapy-induced leucopoenia: protocol for a systematic review.
    Nian J, Sun X, Guo J, Yan C, Wang X, Yang G, Yang L, Yu M, Zhang G.
    BMJ Open; 2016 May 26; 6(5):e010787. PubMed ID: 27231002
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of probiotic in preventing and treating antibiotic-associated diarrhoea and/or Clostridium difficile-associated diarrhoea in patients with spinal cord injury: a protocol of systematic review of randomised controlled trials.
    Wong S, Jamous A, O'Driscoll J, Sekhar R, Saif M, O'Driscoll S, Lewis S, McKeown E, Hirani SP.
    Syst Rev; 2015 Nov 24; 4():170. PubMed ID: 26596269
    [Abstract] [Full Text] [Related]

  • 9. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy.
    Wasserman E, Hidalgo M, Hornedo J, Cortés-Funes H.
    Bone Marrow Transplant; 1997 Nov 24; 20(9):711-4. PubMed ID: 9384471
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of ginkgo preparations for attention deficit hyperactivity disorder: a systematic review protocol.
    He S, Wang M, Si J, Zhang T, Cui H, Gao X.
    BMJ Open; 2018 Feb 20; 8(2):e020434. PubMed ID: 29463592
    [Abstract] [Full Text] [Related]

  • 11. Role of octreotide in post chemotherapy and/or radiotherapy diarrhea: prophylaxis or therapy?
    Sun JX, Yang N.
    Asia Pac J Clin Oncol; 2014 Jun 20; 10(2):e108-13. PubMed ID: 23297685
    [Abstract] [Full Text] [Related]

  • 12. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315.
    Zachariah B, Gwede CK, James J, Ajani J, Chin LJ, Donath D, Rosenthal SA, Kane BL, Rotman M, Berk L, Kachnic LA.
    J Natl Cancer Inst; 2010 Apr 21; 102(8):547-56. PubMed ID: 20339140
    [Abstract] [Full Text] [Related]

  • 13. Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: a systematic literature review.
    Broder MS, Beenhouwer D, Strosberg JR, Neary MP, Cherepanov D.
    World J Gastroenterol; 2015 Feb 14; 21(6):1945-55. PubMed ID: 25684964
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.
    Arts J, Caenepeel P, Bisschops R, Dewulf D, Holvoet L, Piessevaux H, Bourgeois S, Sifrim D, Janssens J, Tack J.
    Clin Gastroenterol Hepatol; 2009 Apr 14; 7(4):432-7. PubMed ID: 19264574
    [Abstract] [Full Text] [Related]

  • 15. Herbal medicine (Hyeolbuchukeo-tang or Xuefu Zhuyu decoction) for treating primary dysmenorrhoea: protocol for a systematic review of randomised controlled trials.
    Jo J, Leem J, Lee JM, Park KS.
    BMJ Open; 2017 Jun 15; 7(6):e015056. PubMed ID: 28619773
    [Abstract] [Full Text] [Related]

  • 16. Acupuncture for patients with chronic urticaria: a systematic review protocol.
    Yao Q, Ye Y, Liu X, Qin Z, Liu Z.
    BMJ Open; 2015 Sep 02; 5(9):e007704. PubMed ID: 26338683
    [Abstract] [Full Text] [Related]

  • 17. Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial.
    Grooteman KV, van Geenen EJ, Drenth JP.
    BMJ Open; 2016 Sep 12; 6(9):e011442. PubMed ID: 27619827
    [Abstract] [Full Text] [Related]

  • 18.
    Kongsgaard U, Kaasa S, Dale O, Ottesen S, Nordøy T, Hessling SE, von Hofacker S, Bruland ØS, Lyngstadaas A.
    ; 2005 12 12. PubMed ID: 29320015
    [Abstract] [Full Text] [Related]

  • 19. Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children.
    O'Meara M, Cicalese MP, Bordugo A, Ambrosi A, Hadzic N, Mieli-Vergani G.
    J Pediatr Gastroenterol Nutr; 2015 Jan 12; 60(1):48-53. PubMed ID: 25162361
    [Abstract] [Full Text] [Related]

  • 20. Chinese patent medicine Fei-Liu-Ping ointment as an adjunctive treatment for non-small cell lung cancer: protocol for a systematic review.
    Zheng H, He S, Liu R, Xu X, Xu T, Chen S, Guo Q, Gao Y, Hua B.
    BMJ Open; 2017 Jan 16; 7(1):e015045. PubMed ID: 28093444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.